Bioton

Bioton EBIT

The EBIT of Bioton (BIO.WA) as of Oct 9, 2026 is 12.81 M PLN. In the previous year, EBIT was -5.71 M PLN — a change of -324.40% (higher).

EBIT

12.81 MPLN

YoY

-324.40%

Last updated:

In 2025, Bioton's EBIT was 12.81 M PLN, a -324.40% increase from the -5.71 M PLN EBIT recorded in the previous year.

The Bioton EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT
Date
EBIT
Jan 1, 2020
48.58 M PLN
Jan 1, 2021
18.98 M PLN
Jan 1, 2022
13.40 M PLN
Jan 1, 2023
15.66 M PLN
Jan 1, 2024
-5.71 M PLN
Jan 1, 2025
12.81 M PLN
Jan 1, 2026 (e)
22.69 M PLN
Jan 1, 2027 (e)
35.74 M PLN
The Bioton EBIT history
YEAREBITYoY
est35.74 MPLN+57.47%
est22.69 MPLN+77.15%
12.81 MPLN-324.40%
-5.71 MPLN-136.45%
15.66 MPLN+16.91%
13.40 MPLN-29.42%
18.98 MPLN-60.93%
48.58 MPLN-131.46%
-154.44 MPLN-765.78%
23.20 MPLN+28.66%
18.03 MPLN-229.77%
-13.89 MPLN-97.24%
-502.86 MPLN-2,374.74%
22.11 MPLN+103.11%
10.88 MPLN-83.74%
66.95 MPLN-231.11%
-51.06 MPLN-166.03%
77.33 MPLN-113.62%
-567.84 MPLN+694.33%
-71.49 MPLN-171.32%
100.23 MPLN+33.90%
74.86 MPLN—
Access this data via the Eulerpool API

Bioton Revenue

Bioton Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2020
221.79 M PLN
48.58 M PLN
33.92 M PLN
Jan 1, 2021
163.03 M PLN
18.98 M PLN
2.88 M PLN
Jan 1, 2022
233.16 M PLN
13.40 M PLN
1.42 M PLN
Jan 1, 2023
181.64 M PLN
15.66 M PLN
2.28 M PLN
Jan 1, 2024
207.76 M PLN
-5.71 M PLN
-15.66 M PLN
Jan 1, 2025
282.52 M PLN
12.81 M PLN
3.39 M PLN
Jan 1, 2026 (e)
266.00 M PLN
22.69 M PLN
12.02 M PLN
Jan 1, 2027 (e)
285.00 M PLN
35.74 M PLN
22.32 M PLN

Bioton Margins

Bioton stock margins

The Bioton margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Bioton. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Bioton.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2020
47.21 %
21.90 %
15.29 %
Jan 1, 2021
46.81 %
11.64 %
1.77 %
Jan 1, 2022
41.07 %
5.75 %
0.61 %
Jan 1, 2023
40.11 %
8.62 %
1.25 %
Jan 1, 2024
31.21 %
-2.75 %
-7.54 %
Jan 1, 2025
34.24 %
4.53 %
1.20 %
Jan 1, 2026 (e)
34.24 %
8.53 %
4.52 %
Jan 1, 2027 (e)
34.24 %
12.54 %
7.83 %

Bioton Stock analysis

What does Bioton do? Bioton SA is a leading Polish biotechnology company specializing in the development of innovative drugs, diagnostics, and medical devices. The company was founded in 1989 and has since achieved remarkable success. Bioton is headquartered in Poland and employs approximately 1000 people worldwide. The company is listed on the Warsaw Stock Exchange and is supported by renowned investors. Business model Bioton operates various business divisions, including research and development, production, sales, as well as marketing and distribution. The company collaborates closely with leading academic institutions and research organizations and invests significant resources in the development of new groundbreaking technologies and products. The company's products and services are distributed and used in over 60 countries worldwide. Divisions Bioton is divided into three main business sectors, including biopharmaceuticals, diagnostics, and medical devices. Biopharmaceuticals Bioton is known for its biopharmaceuticals, particularly insulin and insulin analogs. Insulin is a hormone produced by the body to regulate blood sugar levels. Bioton offers various insulin products, including human insulin, insulin glargine, and insulin aspart. These products are approved for the treatment of diabetes mellitus and are distributed in over 50 countries worldwide. Diagnostics Bioton is also involved in the development and production of diagnostics. The company offers various testing systems for the diagnosis of infectious diseases, allergies, and autoimmune diseases. The product line also includes in vitro diagnostics that are used for medical therapy monitoring and disease detection. Medical devices Bioton also manufactures and distributes medical devices such as insulin pumps and blood glucose meters. These devices are designed for people with diabetes and assist in accurate insulin dosing and blood sugar level monitoring. Products In addition to insulin and insulin analogs, Bioton also produces a wide range of other drugs, including growth hormones, as well as follicle-stimulating hormone (FSH) and luteinizing hormone (LH). These hormones are used for the treatment of infertility. Bioton is also involved in the development of novel technologies such as RNA interference (RNAi) and genomic research. The company invests significantly in innovative research projects aimed at the development of groundbreaking drugs and therapies. In conclusion, Bioton SA is a highly innovative biotechnology company with a wide range of products and a focus on research and development. The company operates in the global market and collaborates closely with renowned institutions and research organizations. Bioton's business model is based on the development of innovative technologies and products aimed at improving the quality of life for people worldwide. Bioton is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing Bioton's EBIT

Bioton's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Bioton's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Bioton's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Bioton’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Bioton stock

EBIT of Bioton is 12.81 M PLN in 2025.

EBIT of Bioton changed from -5.71 M PLN to 12.81 M PLN, representing a -324.40% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT Bioton since 2006 – with annual values, charts, and detailed analysis.

"Earnings before interest and taxes", abbreviated as EBIT, is also referred to as the operating result of a company. It is a key figure that allows the profit to be assessed over a specific period of time, usually a fiscal year. Taxes and interest are not deducted from EBIT, making it suitable for international comparisons of different companies.

Net income
+ Tax expense
+ Interest expense and other financial expenses
- Interest income and other financial income
= EBIT (operating profit)

EBIT's PLN is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT's Bioton historically and in real time.

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

Income Statement — Bioton

All Key Metrics — Bioton